PURPOSE: The authors previously developed magnetic resonance (MR)-trackable magnetocapsules (MCs) that can simultaneously immunoprotect human islet cells and noninvasively monitor portal delivery and engraftment in real time with MR imaging. This study was designed to assess the physiologic effects of the delivery of a clinical dose of MCs (140,000 capsules) into the portal vein (PV) in swine over a 1-month period. MATERIALS AND METHODS: MCs were formed by using clinical-grade alginate mixed with a clinically applicable dosage of ferumoxide. Percutaneous access into the PV was obtained by using a custom-built, MR-trackable needle, and 140,000 MCs were delivered under MR guidance in five swine. Portal pressures and liver function data were obtained over a 4-week period. RESULTS: A transient increase in portal pressure occurred immediately after MC delivery that returned to normal levels by 4 weeks after MC delivery. Liver function test results were normal during the entire period, and the appearance of the MCs on MR imaging did not change. CONCLUSIONS: A clinically applicable dose of 140,000 MCs has no adverse effects on portal pressures or liver function in this normal swine model during the first month after delivery.
PURPOSE: The authors previously developed magnetic resonance (MR)-trackable magnetocapsules (MCs) that can simultaneously immunoprotect human islet cells and noninvasively monitor portal delivery and engraftment in real time with MR imaging. This study was designed to assess the physiologic effects of the delivery of a clinical dose of MCs (140,000 capsules) into the portal vein (PV) in swine over a 1-month period. MATERIALS AND METHODS:MCs were formed by using clinical-grade alginate mixed with a clinically applicable dosage of ferumoxide. Percutaneous access into the PV was obtained by using a custom-built, MR-trackable needle, and 140,000 MCs were delivered under MR guidance in five swine. Portal pressures and liver function data were obtained over a 4-week period. RESULTS: A transient increase in portal pressure occurred immediately after MC delivery that returned to normal levels by 4 weeks after MC delivery. Liver function test results were normal during the entire period, and the appearance of the MCs on MR imaging did not change. CONCLUSIONS: A clinically applicable dose of 140,000 MCs has no adverse effects on portal pressures or liver function in this normal swine model during the first month after delivery.
Authors: Gorka Orive; Rosa María Hernández; Alicia R Gascón; Riccardo Calafiore; Thomas M S Chang; Paul De Vos; Gonzalo Hortelano; David Hunkeler; Igor Lacík; A M James Shapiro; José Luis Pedraz Journal: Nat Med Date: 2003-01 Impact factor: 53.440
Authors: Christian Toso; Zoltan Mathe; Philippe Morel; José Oberholzer; Domenico Bosco; Dianelys Sainz-Vidal; David Hunkeler; Leo H Buhler; Christine Wandrey; Thierry Berney Journal: Cell Transplant Date: 2005 Impact factor: 4.064
Authors: T D Zekorn; A Horcher; J Mellert; U Siebers; T Altug; A Emre; H J Hahn; K Federlin Journal: Int J Artif Organs Date: 1996-04 Impact factor: 1.595
Authors: D Pavcnik; R R Saxon; Y Kubota; H Tanihata; B T Uchida; C Corless; F S Keller Journal: J Vasc Interv Radiol Date: 1997 Jan-Feb Impact factor: 3.464
Authors: Z Mathe; P Bucher; D Bosco; A Andres; C Fux; C Toso; J Oberholzer; C Wandrey; D Sainz-Vidal; D Espinosa; L Bühler; P Morel; T Berney Journal: Transplant Proc Date: 2004-05 Impact factor: 1.066
Authors: P V Karmarkar; D L Kraitchman; I Izbudak; L V Hofmann; L C Amado; D Fritzges; R Young; M Pittenger; J W M Bulte; E Atalar Journal: Magn Reson Med Date: 2004-06 Impact factor: 4.668
Authors: Christian Toso; José Oberholzer; Ion Ceausoglu; Frédéric Ris; Bertrand Rochat; Annemie Rehor; Pascal Bucher; Christine Wandrey; Ute Schuldt; Jacques Belenger; Domenico Bosco; Philippe Morel; David Hunkeler Journal: Transpl Int Date: 2003-03-20 Impact factor: 3.782
Authors: Dian R Arifin; Christopher M Long; Assaf A Gilad; Christophe Alric; Stéphane Roux; Olivier Tillement; Thomas W Link; Aravind Arepally; Jeff W M Bulte Journal: Radiology Date: 2011-07-06 Impact factor: 11.105
Authors: Thomas W Link; Dian R Arifin; Christopher M Long; Piotr Walczak; Naser Muja; Aravind Arepally; Jeff W M Bulte Journal: Cell Med Date: 2012-02-01
Authors: Dian R Arifin; Dorota A Kedziorek; Yingli Fu; Kannie W Y Chan; Michael T McMahon; Clifford R Weiss; Dara L Kraitchman; Jeff W M Bulte Journal: NMR Biomed Date: 2012-12-07 Impact factor: 4.044
Authors: Dian R Arifin; Steffi Valdeig; Robert A Anders; Jeff W M Bulte; Clifford R Weiss Journal: Xenotransplantation Date: 2016-05-26 Impact factor: 3.907
Authors: B S Ungureanu; C Margaritescu; D Pirici; I A Gheonea; N F Trincu; A Fifere; D R Tudorascu; A Saftoiu Journal: Curr Health Sci J Date: 2015-12-22